Our platform allows delivery of “difficult to deliver” drugs across a variety of therapeutic areas and clinical indications. Our hybrid platform overcomes challenges associated with lipidic and polymeric nanoparticle systems. NanobridTM Platform is flexible and can be adapted to various routes of administration such as topical, injectables, ocular, nasal, oral etc. to design products with superior value propositions